Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Merlin for Recurrent Herpes Labialis
NCT01985321Phase 2Completed
- Sponsor
- Topical Remedy
- Start
- Nov 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in herpes labialis comparing Merlin with Placebo (2 arms). Primary endpoint: Clinician Assessed Duration of Complete Healing of the Herpetic Episode. Started Nov 2013; status: completed.
02
Drugs
Ethanol + glycolic acid
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT01985321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01985321.